Hormone Replacement Therapy Market to be Dominated by Increase in Uptake of Parathyroid Hormone
Increase in technological
advancements associated with hormone replacement therapy along with development
of novel drugs and new products are the major drivers for the global hormone replacement therapy market.
According to TechSci Research
report, “Global Hormone Replacement Therapy Market – Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”, the global hormone
replacement therapy market is anticipated to register a high CAGR during the
forecast period. This can be ascribed to developing economy of countries and
increase in healthcare expenditure across the world.
Parathyroid hormone
(PTH) is a hormone that regulates the levels of calcium and phosphate in the
body. It is often used as a treatment for osteoporosis which is one of the most
prevalent diseases among geriatric people across the world. The use of
parathyroid hormones in hormone replacement therapy is new development and has
shown excellent results in improving bone density and reducing the risk of
fractures. United States of America, Asia, and Europe are some of the leading
countries which account for the highest number of osteoporosis cases across the
world. In the United States, more than 10 million people have osteoporosis, and
another 44 million have low bone density, which places them at increased risk
for the condition. Moreover, In Europe, an estimated 22 million women and 5.5
million men over the age of 50 have osteoporosis. Growing incidences of bone
diseases in the world are leading to rise in uptake of parathyroid hormone
which is further expected to register a lucrative growth to global hormone
replacement therapy market in the futuristic period. Increase in technological
advancements coupled with improvement in hormone replacement therapy are one of
the significant factors which is expected to propel the growth of market in the
forecast period.
Adoption of various
technologies have led to the development of new delivery methods in the market
such as transdermal patches, gels, and creams which is making the hormone
replacement therapy more accessible and convenient for patients. The global
hormone replacement therapy market has been growing steadily over the past few
years, and this growth is primarily driven by the increasing demand for novel
drugs and new products that offer improved safety and efficacy to people.
Furthermore, the development of new drugs with better safety profiles and fewer
side effects has contributed to the growth of the hormone replacement therapy
market. For instance, selective estrogen receptor modulators (SERMs) such as
raloxifene and bazedoxifene have been developed as an alternative to
traditional estrogen therapy for the prevention and treatment of osteoporosis.
Hormone Replacement Therapy has emerged as a promising factor for management of
various types of cancer such as breast cancer and prostate cancer. Prostate
cancer cells need testosterone to grow and divide, hormone replacement therapy
reduces the levels of testosterone in the body, which thereby slows down the
growth of cancer cells. HRT for prostate cancer is usually given in the form of
drugs that block the production of testosterone or block the effects of
testosterone on the cancer cells. Furthermore, development in economy of
various countries across the world which is leading to the rise in healthcare
expenditure made by people to take care of their health through reliable
therapeutic methods are expected to register an impressive growth to global
hormone replacement therapy market in the forecast period.
However, adverse effects
of these therapies and shortage of premium therapeutic products in the market
due to weak pipelines are expected to slow down the growth of the market in the
coming years.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global
Hormone Replacement Therapy Market”
The global hormone replacement therapy market segmentation is
based on product, route of administration, disease type, by company, and region.
Based on route of
administration, the market is further divided into oral, parenteral,
transdermal, and others. Oral segment is likely to dominate the market in the
forecast period. This can be ascribed to
its high prescription rate and ease of administration in the market.
Some of the major
companies operating in the global hormone replacement therapy market include:
- Bayer AG
- Pfizer Inc.
- Merck & Co.,
Inc.
- Viatris Inc.
- Novo Nordisk A/S
- Eli Lilly and
Company
- F. Hoffmann-La
Roche Ltd. (Genentech)
- Hisamitsu
Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
- ASCEND
Therapeutics US, LLC. (Besins Healthcare)
- AbbVie Inc.
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Certain regions are expected to dominate the demand for hormone
replacement therapy in the world. Improvement in quality of various therapeutic
products due to the availability of multiple companies in the market which are
manufacturing hormone replacement therapy products are expected to register an
impressive growth to global hormone replacement therapy market in the forecast
period," said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
“Hormone Replacement Therapy Market - Global
Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028
Segmented By Product (Estrogen & Progesterone Replacement Therapy, HGH
Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone
Replacement Therapy, and Parathyroid Hormone Replacement), By Route of
Administration (Oral, Parenteral, Transdermal, and Others), By Disease Type
(Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, and
Hypoparathyroidism), By Region and Competition”, has evaluated the future
growth potential of global hormone replacement therapy market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global hormone replacement therapy market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com